UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Pharmacokinetics and metabolism of idebenone in healthy male subjects

European journal of clinical pharmacology, 2009-05, Vol.65 (5), p.493-501

2009

Volltextzugriff (PDF)

Reduced Inter- and Intraindividual Variability in Cyclosporine Pharmacokinetics from a Microemulsion Formulation

Journal of pharmaceutical sciences, 1994-03, Vol.83 (3), p.444-446

1994

Volltextzugriff (PDF)

Mo1922 - Phase I Randomized Controlled Study of a Single-Strain Live Biotherapeutic (Blautia Hydrogenotrophica) in the Treatment of Patients with Irritable Bowel Syndrome (IBS): Effects on the Microbiome

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-852-S-853

2018

Volltextzugriff (PDF)

Cyclosporine pharmacokinetics and variability from a microemulsion formulation--a multicenter investigation in kidney transplant patients

Transplantation, 1994-09, Vol.58 (6), p.658

1994

Volltextzugriff (PDF)

Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma

Journal of allergy and clinical immunology, 2015-09, Vol.136 (3), p.797-800

2015

Volltextzugriff (PDF)

Pharmacokinetic properties and metabolism of idebenone

Journal of neurology, 2009-03, Vol.256 (Suppl 1), p.31-35

2009

Volltextzugriff (PDF)

Within-day consistency in cyclosporine pharmacokinetics from a microemulsion formulation in renal transplant patients

Therapeutic drug monitoring, 1994-06, Vol.16 (3), p.232-237

1994

Volltextzugriff (PDF)

Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH 2-driven asthma

Journal of allergy and clinical immunology, 2015, Vol.136 (3), p.797-800

2015

Volltextzugriff (PDF)

Bioequivalence of Soft Gelatin Capsules and Oral Solution of a New Cyclosporine Formulation

Pharmacotherapy, 1993-11, Vol.13 (6), p.613-617

1993

Volltextzugriff (PDF)

Diminishing efficacy of octreotide (SMS 201-995) on gastric functions of healthy subjects during one-week administration

Gastroenterology (New York, N.Y. 1943), 1989-03, Vol.96 (3), p.713-722

1989

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of the ETA-Selective Endothelin Receptor Antagonist SPP301 in Healthy Human Subjects

Journal of clinical pharmacology, 2004-01, Vol.44 (1), p.59-66

2004

Volltextzugriff (PDF)

Results of a Phase II Study of Pixantrone in Combination with Cyclophosphamide, Vincristine, and Prednisone in Patients with Relapsed Aggressive Non-Hodgkin's Lymphoma

Blood, 2006-11, Vol.108 (11), p.529-529

2006

Volltextzugriff (PDF)

Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation

Pharmaceutical research, 1994-02, Vol.11 (2), p.301-304

1994

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of the ET A ‐Selective Endothelin Receptor Antagonist SPP301 in Healthy Human Subjects

Journal of clinical pharmacology, 2004-01, Vol.44 (1), p.59-66

2004

Volltextzugriff (PDF)

Influence of Food Intake and Formulation on the Pharmacokinetics and Metabolism of Bosentan, a Dual Endothelin Receptor Antagonist

Journal of clinical pharmacology, 2002-03, Vol.42 (3), p.283-289

2002

Volltextzugriff (PDF)

Preliminary Phase II Study Results of BBR2778 in Combination with Cyclophosphamide, Vincristine, and Prednisone in Patients with Relapsed Aggressive Non-Hodgkin's Lymphoma

Blood, 2004-11, Vol.104 (11), p.2489-2489

2004

Volltextzugriff (PDF)

Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients--a concentration-controlled comparison with the commercial formulation

Transplantation, 1994-04, Vol.57 (8), p.1178

1994

Volltextzugriff (PDF)

Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation

Pharmaceutical research, 1994, Vol.11 (1), p.151-155

1994

Volltextzugriff (PDF)

Phase I clinical and pharmacokinetic study of BBR 3576, a novel aza-anthrapyrazole, administered i.v. every 4 weeks in patients with advanced solid tumors: a phase I study group trial of the Central European Society of Anticancer-Drug Research (CESAR)

Anti-cancer drugs, 2004-01, Vol.15 (1), p.15-22

2004

Volltextzugriff (PDF)

Lack of interaction between fluvastatin andoral nypoylycemie agents in healthy subjects and in patients with non-insulin-dependent diabetes mellitus

The American journal of cardiology, 1995-07, Vol.76 (1), p.29A-32A

1995

Volltextzugriff (PDF)

Influence of food intake and fromulation on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist

Journal of clinical pharmacology, 2002-03, Vol.42 (3), p.283

2002

Volltextzugriff (PDF)

Influence of Food Intake and Formulation on the Pharmacokinetics and Metabolism of Bosentan, a Dual Endothelin Receptor Antagonist

Journal of clinical pharmacology, 2002-03, Vol.42 (3), p.283-289

2002

Volltextzugriff (PDF)

A comparison of octreotide, bromocriptine, or a combination of both drugs in acromegaly

The journal of clinical endocrinology and metabolism, 1994-08, Vol.79 (2), p.461-465

1994

Volltextzugriff (PDF)

Diminishing Efficacy of Octreotide (SMS 201-995) on Gastric Functions of Healthy Subjects During One-Week Administration

Gastroenterology (New York, N.Y. 1943), 1989-02, Vol.96 (2), p.713-722

1989

Volltextzugriff (PDF)

Pharmacokinetics of Orally Administered Cyclosporine in Patients with Crohn's Disease

Journal of clinical pharmacology, 1995-07, Vol.35 (7), p.681-687

1995

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(21)
Male
(21)
Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Adult
(18)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Pharmacology. Drug Treatments
(14)
Female
(12)
Pharmacology & Pharmacy
(10)
Cyclosporine - Pharmacokinetics
(9)
Middle Aged
(9)
Administration, Oral
(8)
Cyclosporine - Administration & Dosage
(8)
Immunomodulators
(8)
Pharmacokinetics
(7)
Area Under Curve
(6)
Emulsions
(6)
Dose-Response Relationship, Drug
(5)
Half-Life
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics and metabolism of idebenone in healthy male subjects

Reduced Inter- and Intraindividual Variability in Cyclosporine Pharmacokinetics from a Microemulsion Formulation

Mo1922 - Phase I Randomized Controlled Study of a Single-Strain Live Biotherapeutic (Blautia Hydrogenotrophica) in the Treatment of Patients with Irritable Bowel Syndrome (IBS): Effects on the Microbiome

Cyclosporine pharmacokinetics and variability from a microemulsion formulation--a multicenter investigation in kidney transplant patients

Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma

Pharmacokinetic properties and metabolism of idebenone

Within-day consistency in cyclosporine pharmacokinetics from a microemulsion formulation in renal transplant patients

Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH 2-driven asthma

Bioequivalence of Soft Gelatin Capsules and Oral Solution of a New Cyclosporine Formulation

Diminishing efficacy of octreotide (SMS 201-995) on gastric functions of healthy subjects during one-week administration

Pharmacokinetics and Pharmacodynamics of the ETA-Selective Endothelin Receptor Antagonist SPP301 in Healthy Human Subjects

Results of a Phase II Study of Pixantrone in Combination with Cyclophosphamide, Vincristine, and Prednisone in Patients with Relapsed Aggressive Non-Hodgkin's Lymphoma

Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation

Pharmacokinetics and Pharmacodynamics of the ET A ‐Selective Endothelin Receptor Antagonist SPP301 in Healthy Human Subjects

Influence of Food Intake and Formulation on the Pharmacokinetics and Metabolism of Bosentan, a Dual Endothelin Receptor Antagonist

Preliminary Phase II Study Results of BBR2778 in Combination with Cyclophosphamide, Vincristine, and Prednisone in Patients with Relapsed Aggressive Non-Hodgkin's Lymphoma

Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients--a concentration-controlled comparison with the commercial formulation

Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation

Phase I clinical and pharmacokinetic study of BBR 3576, a novel aza-anthrapyrazole, administered i.v. every 4 weeks in patients with advanced solid tumors: a phase I study group trial of the Central European Society of Anticancer-Drug Research (CESAR)

Lack of interaction between fluvastatin andoral nypoylycemie agents in healthy subjects and in patients with non-insulin-dependent diabetes mellitus

Influence of food intake and fromulation on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist

Influence of Food Intake and Formulation on the Pharmacokinetics and Metabolism of Bosentan, a Dual Endothelin Receptor Antagonist

A comparison of octreotide, bromocriptine, or a combination of both drugs in acromegaly

Diminishing Efficacy of Octreotide (SMS 201-995) on Gastric Functions of Healthy Subjects During One-Week Administration

Pharmacokinetics of Orally Administered Cyclosporine in Patients with Crohn's Disease

Suchergebnisse filtern